STI-7349
/ The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 25, 2025
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=183 | Recruiting | Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | N=124 ➔ 183 | Trial completion date: Dec 2025 ➔ Jun 2027 | Trial primary completion date: Dec 2025 ➔ Jun 2027
Enrollment change • Trial completion date • Trial primary completion date • Solid Tumor
January 16, 2024
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=124 | Recruiting | Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
August 07, 2023
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=124 | Not yet recruiting | Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Metastases • New P1/2 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1